Chanteal Findling, DO
Family Medicine · Kansas City, MONPI 1619590270
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for family medicine clinicians in MO, where the typical reported total is $366.
Across 16 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$54
- Lilly USA, LLC$50
- Astellas Pharma US Inc$38
- AstraZeneca$31
- AbbVie$30
- Phathom Pharmaceuticals, Inc.$22
- plus $70 from 4 others
What the payments were for
- Food & beverage$295100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 3 | $54 |
| Lilly USA, LLC | 3 | $50 |
| Astellas Pharma US Inc | 2 | $38 |
| AstraZeneca | 2 | $31 |
| AbbVie | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| Boehringer Ingelheim | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Exact Sciences | 1 | $14 |
How this compares
$295 in reported general payments places this provider in the 45th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,348 |
| Gabapentin | 50 | $826 |
| Levothyroxine Sodium | 57 | $802 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $761 |
| Atorvastatin Calcium | 97 | $698 |
| Omeprazole | 45 | $632 |
| Losartan Potassium | 58 | $598 |
| Famotidine | 30 | $452 |
| Olmesartan Medoxomil | 15 | $451 |
| Amlodipine Besylate | 90 | $437 |
| Rosuvastatin Calcium | 20 | $374 |
| Pantoprazole Sodium | 54 | $332 |
| Metoprolol Succinate | 16 | $311 |
| Chlorthalidone | 11 | $270 |
| Duloxetine Hcl | 18 | $266 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Kansas City
- Blair ThedingerKansas City$71K
- Jon MattsonKansas City$53K
- Meredith LevineKansas City$26K
- Kelly SandriKansas City$17K
- Michael SimanovskyKansas City$16K
- Teresa MarshallKansas City$16K
- Nora GomezKansas City$15K
- Julie AlvarezKansas City$15K
- Neal MooreKansas City$14K
- Stephen AdamsSpringfield$636K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.